HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Potassium Carbonate → 3-{[4-(6-Fluoro-1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl]methyl}-2,3-dihydro[1,4]dioxino[2,3-b]pyridine

HRID 1611411
Print

Reaction equation

HRID 1611411 reaction equation
[F:1][C:2]1[CH:10]=[C:9]2[C:5]([C:6]([C:11]3[CH2:12][CH2:13][NH:14][CH2:15][CH:16]=3)=[CH:7][NH:8]2)=[CH:4][CH:3]=1.Br[C:18]1[C:23]([O:24][CH2:25][C@@H:26]2[CH2:28][O:27]2)=[CH:22][CH:21]=[CH:20][N:19]=1.C(=O)([O-])[O-].[K+].[K+]>CS(C)=O.C1(C)C=CC=CC=1.C([O-])(=O)C.[Pd+2].C([O-])(=O)C.CC1C=CC(P(C2C=CC3C(=CC=CC=3)C=2C2C3C(=CC=CC=3)C=CC=2P(C2C=CC(C)=CC=2)C2C=CC(C)=CC=2)C2C=CC(C)=CC=2)=CC=1>[F:1][C:2]1[CH:10]=[C:9]2[C:5]([C:6]([C:11]3[CH2:12][CH2:13][N:14]([CH2:28][CH:26]4[O:27][C:18]5=[N:19][CH:20]=[CH:21][CH:22]=[C:23]5[O:24][CH2:25]4)[CH2:15][CH:16]=3)=[CH:7][NH:8]2)=[CH:4][CH:3]=1
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

8

Reactant 3

HCID 11430Potassium CarbonateHCID 110530726-fluoro-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoleHCID 120981832-bromo-3-[(2S)-oxiranylmethoxy]pyridine

Product 1

HCID 101557163-{[4-(6-Fluoro-1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl]methyl}-2,3-dihydro[1,4]dioxino[2,3-b]pyridineYield 79%

Reagents, catalysts & solvents 4

HCID 167845
palladium(II) acetate
Catalyst
HCID 4189906(S)-(-)-2,2'-Bis(di-p-tolylphosphino)-1, 1'-binaphthylCatalyst
HCID 679Dimethyl SulfoxideSolvent
HCID 1140TolueneSolvent

Procedure

6-Fluoro-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole (1.87 g, 8.65 mmole) and 2-bromo-3-[(2S)oxiranylmethoxy]pyridine (1.00 g, 4.34 mmole) were combined in DMSO (45 mL). This solution was heated at 75–80° C. under nitrogen for 5 hours. After completion, the reaction was cooled to room temperature and partitioned between 250 mL each of ethyl acetate and saturated sodium bicarbonate. The organic phase was washed with brine, dried over magnesium sulfate and concentrated in vacuum. The crude oil was column chromatographed on silica gel using first methylene chloride as eluant to remove impurities and then 3% methanol in methylene chloride to elute the product, which was a yellow solid (0.30 g, 15%). The intermediate (0.30 g, 0.67 mmole) was then cyclized in toluene (40 mL) in the presence of palladium (II) acetate (0.010 g, 0.044 mmole), (S)-(−)-2,2′-bis(di-p-tolylphosphino)-1,1′-binaphthyl (0.030 g, 0.044 mmole), and potassium carbonate (0.11 g, 0.80 mmole). The heterogeneous mixture was heated at 100° C. for a period of 24 hours. After the mixture cooled to room temperature, the catalysts were removed by filtration and the filtrate was concentrated in vacuum. The resulting crude brown oil was then column chromatographed on silica gel with 3% methanol in methylene chloride to give the desired product as a brown oil (0.19 g, 79%). The oil was crystallized from ethanol with the addition of a solution of oxalic acid in hot ethanol to give 0.070 g of the (S)-enantiomer of the title compound as beige solid dioxalate, m.p. 120° C.

Workup

  1. temperatureThis solution was heated at 75–80° C. under nitrogen for 5 hours
  2. custompartitioned between 250 mL each of ethyl acetate and saturated sodium bicarbonate
  3. washThe organic phase was washed with brine
  4. dry with materialdried over magnesium sulfate
  5. concentrationconcentrated in vacuum
  6. customchromatographed on silica gel using first methylene chloride as eluant
  7. customto remove impurities
  8. wash3% methanol in methylene chloride to elute the product, which
  9. temperatureThe heterogeneous mixture was heated at 100° C. for a period of 24 hours
  10. temperatureAfter the mixture cooled to room temperature
  11. customthe catalysts were removed by filtration
  12. concentrationthe filtrate was concentrated in vacuum
  13. customcolumn chromatographed on silica gel with 3% methanol in methylene chloride

Sources & evidence

ORD record
ord-daca2b9b722a4828a3d3c473ae512567
Source dataset
uspto-grants-2006_01
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US06987117B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes